Skip to content

Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples

Papillary Thyroid Cancer

The purpose of this study is to determine whether results from a fine needle biopsy are the same as results from a larger sample that is acquired from the surgical pathology using the Thyroid GuidePx® test in patients with papillary thyroid carcinoma.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* Age ≥ 18 years
* A diagnosis of papillary thyroid cancer based on a fine needle biopsy (FNB) interpreted as a Bethesda V or VI cytology
* Tumor size \> 1 cm in maximal diameter
* The patient is an operative candidate
* The patient has provided consent

Exclusion Criteria:

* Family history of thyroid cancer
* History of radiation to the neck
* Unable or unwilling to have a fine needle biopsy
* Unwilling to undergo thyroidectomy
* Final pathology does not demonstrate papillary thyroid cancer
* Cases where there is no clear dominant nodule
* Cases where there are multiple nodules that preclude sampling of a defined nodule

Study Location

Foothills Medical Centre
Foothills Medical Centre
Calgary, Alberta
Canada

Contact Study Team

Primary Contact

Elleine Allapitan

4032208440
Study Sponsored By
University of Calgary
Participants Required
More Information
Study ID: NCT06133374